Literature DB >> 24906368

High tobacco consumption is causally associated with increased all-cause mortality in a general population sample of 55,568 individuals, but not with short telomeres: a Mendelian randomization study.

Line Rode1, Stig E Bojesen1, Maren Weischer1, Børge G Nordestgaard2.   

Abstract

BACKGROUND: High cumulative tobacco consumption is associated with short telomeres and with increased all-cause mortality. We tested the hypothesis that high tobacco consumption is causally associated with short telomeres and with increased all-cause mortality.
METHODS: We studied 55,568 individuals including 32,823 ever smokers from the Danish general population, of whom 3430 died during 10 years of follow-up. All had telomere length measured, detailed information on smoking history, and CHRNA3 rs1051730 genotype, which is associated with tobacco consumption, determined. In a Mendelian randomization study, we conducted observational, genetic, and mediation analyses.
RESULTS: First, tobacco consumption was 21.1 pack-years in non-carriers, 22.8 in heterozygotes and 24.8 in homozygotes (P-trend<0.001). Second, the observational multivariable adjusted hazard ratio for all-cause mortality was 1.12 [95% confidence interval (CI): 1.09, 1.15] per doubling in tobacco consumption. In Mendelian randomization analysis, the hazard ratio was 1.08 (1.02, 1.14) per minor CHRNA3 allele in ever smokers. Third, in observational analysis telomeres shortened with -13 base pairs (-18, -8) per doubling in tobacco consumption. In Mendelian randomization analysis, the estimate was +3 base pairs (-10, +15) per minor CHRNA3 allele. Finally, individuals with the shortest vs longest telomeres had a multivariable adjusted hazard ratio of 1.30 (1.13, 1.50) for all-cause mortality; however, in mediation analysis short telomeres explained only +0.4% (-3.5%, +4.3%) of the association between high tobacco consumption and increased all-cause mortality.
CONCLUSIONS: High tobacco consumption is causally associated with increased all-cause mortality. High cumulative tobacco consumption is associated with short telomeres observationally, but there is no clear genetic association.
© The Author 2014; all rights reserved. Published by Oxford University Press on behalf of the International Epidemiological Association.

Entities:  

Keywords:  Mendelian randomization; Telomere length; mediation; mortality; smoking

Mesh:

Year:  2014        PMID: 24906368     DOI: 10.1093/ije/dyu119

Source DB:  PubMed          Journal:  Int J Epidemiol        ISSN: 0300-5771            Impact factor:   7.196


  17 in total

Review 1.  Epidemiology of cardiovascular disease: recent novel outlooks on risk factors and clinical approaches.

Authors:  Teemu J Niiranen; Ramachandran S Vasan
Journal:  Expert Rev Cardiovasc Ther       Date:  2016-04-25

2.  Why are there associations between telomere length and behaviour?

Authors:  Melissa Bateson; Daniel Nettle
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-03-05       Impact factor: 6.237

3.  Association of relative telomere length with progression of chronic kidney disease in two cohorts: effect modification by smoking and diabetes.

Authors:  Julia Raschenberger; Barbara Kollerits; James Ritchie; Beverley Lane; Philip A Kalra; Eberhard Ritz; Florian Kronenberg
Journal:  Sci Rep       Date:  2015-07-07       Impact factor: 4.379

4.  Genetically low vitamin D concentrations and increased mortality: Mendelian randomisation analysis in three large cohorts.

Authors:  Shoaib Afzal; Peter Brøndum-Jacobsen; Stig E Bojesen; Børge G Nordestgaard
Journal:  BMJ       Date:  2014-11-18

Review 5.  Converging findings from linkage and association analyses on susceptibility genes for smoking and other addictions.

Authors:  J Yang; M D Li
Journal:  Mol Psychiatry       Date:  2016-05-10       Impact factor: 15.992

Review 6.  The CHRNA5-A3-B4 Gene Cluster and Smoking: From Discovery to Therapeutics.

Authors:  Glenda Lassi; Amy E Taylor; Nicholas J Timpson; Paul J Kenny; Robert J Mather; Tim Eisen; Marcus R Munafò
Journal:  Trends Neurosci       Date:  2016-11-18       Impact factor: 13.837

7.  High body mass index and cancer risk-a Mendelian randomisation study.

Authors:  Marianne Benn; Anne Tybjærg-Hansen; George Davey Smith; Børge Grønne Nordestgaard
Journal:  Eur J Epidemiol       Date:  2016-04-09       Impact factor: 8.082

8.  Commentary: Does mortality from smoking have implications for future Mendelian randomization studies?

Authors:  Amy E Taylor; Marcus R Munafò
Journal:  Int J Epidemiol       Date:  2014-08-14       Impact factor: 7.196

9.  Effect of Smoking on Blood Pressure and Resting Heart Rate: A Mendelian Randomization Meta-Analysis in the CARTA Consortium.

Authors:  Allan Linneberg; Rikke K Jacobsen; Tea Skaaby; Amy E Taylor; Meg E Fluharty; Jørgen L Jeppesen; Johan H Bjorngaard; Bjørn O Åsvold; Maiken E Gabrielsen; Archie Campbell; Riccardo E Marioni; Meena Kumari; Pedro Marques-Vidal; Marika Kaakinen; Alana Cavadino; Iris Postmus; Tarunveer S Ahluwalia; S Goya Wannamethee; Jari Lahti; Katri Räikkönen; Aarno Palotie; Andrew Wong; Christine Dalgård; Ian Ford; Yoav Ben-Shlomo; Lene Christiansen; Kirsten O Kyvik; Diana Kuh; Johan G Eriksson; Peter H Whincup; Hamdi Mbarek; Eco J C de Geus; Jacqueline M Vink; Dorret I Boomsma; George Davey Smith; Debbie A Lawlor; Aliaksei Kisialiou; Alex McConnachie; Sandosh Padmanabhan; J Wouter Jukema; Chris Power; Elina Hyppönen; Martin Preisig; Gerard Waeber; Peter Vollenweider; Tellervo Korhonen; Tiina Laatikainen; Veikko Salomaa; Jaakko Kaprio; Mika Kivimaki; Blair H Smith; Caroline Hayward; Thorkild I A Sørensen; Betina H Thuesen; Naveed Sattar; Richard W Morris; Pål R Romundstad; Marcus R Munafò; Marjo-Riitta Jarvelin; Lise Lotte N Husemoen
Journal:  Circ Cardiovasc Genet       Date:  2015-11-04

Review 10.  Selecting instruments for Mendelian randomization in the wake of genome-wide association studies.

Authors:  Daniel I Swerdlow; Karoline B Kuchenbaecker; Sonia Shah; Reecha Sofat; Michael V Holmes; Jon White; Jennifer S Mindell; Mika Kivimaki; Eric J Brunner; John C Whittaker; Juan P Casas; Aroon D Hingorani
Journal:  Int J Epidemiol       Date:  2016-06-24       Impact factor: 7.196

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.